La ricercatrice italiana Monica Gostissa è il nuovo direttore scientifico della Egle Therapeutics, azienda biotecnologica specializzata in terapie innovative sui linfociti T per il trattamento di tumori e malattie autoimmuni. [...] Gostissa ha conseguito il dottorato in Genetica molecolare alla Scuola Internazionale Superiore di Studi Avanzati di TRIESTE
Leggi l'articolo qui.
Con un'edizione che guarda alla diversità dei punti di vista nella discussione pubblica sulla scienza e con un cartellone strettamente legato alla visione "al femminile" di prospettive ed esperienze in ambito scientifico e letterario, torna a Trieste da giovedì 16 a martedì 21 maggio "Scienza e Virgola", il science and media festival al traguardo della sua ottava edizione, organizzato dal Laboratorio Interdisciplinare della Sissa.
Leggi l'articolo qui.
La ricercatrice italiana Monica Gostissa è il nuovo direttore scientifico della Egle Therapeutics, azienda biotecnologica specializzata in terapie innovative sui linfociti T per il trattamento di tumori e malattie autoimmuni. [...] Gostissa ha conseguito il dottorato in Genetica molecolare alla Scuola Internazionale Superiore di Studi Avanzati di TRIESTE
Leggi l'articolo qui.
Scienza e Virgola, il Science and Media Festival organizzato dal Laboratorio Interdisciplinare della SISSA, torna a Trieste dal 16 al 21 maggio 2024 con la sua 8^ edizione.
Leggi l'articolo qui.
E' arrivato in tutte le librerie e negli store online la guida "Savona, la Riviera e l'entroterra" di Ilaria Caprioglio e Doriana Rodino [...]. Doriana Rodino dal 2018 al 2021 è stata assessore a Cultura, Musei, Promozione turistica, Campus universitario, Politiche giovanili e Pari Opportunità per il Comune di Savona. Editor e docente per Alpha Test, è dottore di ricerca in Biologia e si è specializzata in Comunicazione della Scienza alla SISSA di Trieste.
Leggi l?articolo qui.
SMACT, il Centro di Competenza Industria 4.0, offre consulenza e formazione alle aziende che vogliono aumentare il proprio potenziale innovativo SMACT è uno degli otto Centri di Competenza Industria 4.0 nati per favorire l'incontro tra ricerca e impresa. I soci fondatori di SMACT sono 8 università del Triveneto (Padova, Verona, Ca' Foscari, IUAV, Trento, Bolzano, Udine e SISSA di Trieste).
Leggi l'articolo qui.
Si chiama Richard Slayman, ha 62 anni, ed è il primo essere umano vivente al mondo ad aver ricevuto un rene di maiale geneticamente modificato. [...] E quali sono gli aspetti bioetici da tener presente quando si effettua uno xenotrapianto e se questa tecnica diventerà una pratica abituale? Rispondono Emanuele Cozzi, [...] e Mariachiara Tallacchini, docente di scienza, diritto e democrazia alla Scuola Internazionale di Studi Superiori Avanzati (SISSA) di Trieste.
Leggi l'articolo qui.
L'opera è stata scritta insieme ad Alessandra Ria [...]. Alessandra Ria è laureata in Molecular Biology and Genetics all'Università di Pavia, si successivamente specializzata in comunicazione della scienza presso la SISSA di Trieste.
Leggi l'articolo qui.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer. [...] Dr. Gostissa obtained her PhD in molecular genetics from the International School for Advanced Studies in Trieste, Italy.
Read the article here.
